nach oben

Erschienen in:

2019 | OriginalPaper | Buchkapitel

35. Lymphproliferative Erkrankungen des Gastrointestinaltrakts

verfasst von : Univ. Prof. Dr. Andreas Chott

Erschienen in: Pathologie

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Der Gastrointestinaltrakt ist häufiger Primärsitz extranodaler Non-Hodgkin-Lymphome und zeigt darüberhinaus in seinem mukosaassoziierten konstitutionellen lymphatischen System eine besondere Prävalenz mancher systemischer Lymphome. Dabei zeigen verschiedene Abschnitte ganz unterschiedliche Befallsmuster. Dieses Kapitel erfasst alle bekannten Entitäten und deren morpholgische, immunhistochemische und genetische Besonderheiten, auf der Basis der neuen WHO Klassifikation abschnittsentsprechend gegliedert. Wichtige diagnostische Eigenschaften werden herausgearbeitet und der primäre und sekundäre Lymphombefall des Darms unterschieden. Auch die organtypischen Neoplasien und klonalen Proliferationen des T-Zell Systems werden behandelt und pathogenetisch, soweit bekannt, zugeordnet. Das Kapitel stellt eine wichtige Aktualisierung für die mit der Diagnostik befassten Pathologen und Kliniker dar.

Attygalle AD, Liu H, Shirali S, Diss TC, Loddenkemper C, Stein H, Dogan A, Du M-Q, Isaacson PG (2004) Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. Blood 104:3343–3348CrossRef

Bagdi E, Diss TC, Munson P, Isaacson PG (1999) Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood 94:260–264PubMed

Bart TFE, Barth CA, Kestler HA, Michl P, Weniger MA, Buchholz M, Möller P, Gress T (2007) Trancriptional profiling suggests that secondary and primary large B-cell lymphomas of the gastrointestinal (GI) tract are blastic variants of GI marginal zone lymphoma. J Pathol 211:305–313CrossRef

Barth TFE, Floßbach L, Möller P (2013) Das Lymphom im Magen. Eine persistierende interdisziplinäre Herausforderung. Pathologe 34:210–214CrossRef

Bende RJ, Smit LA, Bossenbroek JG, Aarts WM, Spaargaren M, de Leval L, Boeckxstaens GEE, Pals ST, van Noesel CJM (2003) Primary follicular lymphoma of the small intestine. α4β7 Expression and immunoglobulin configuration suggest an origin from local antigen-experienced B cells. Am J Pathol 162:105–113CrossRef

Bosman FT, Carneiro F, Hruban RH, Theise ND (Hrsg) (2010) WHO classification of tumours of the digestive system. WHO, IARC Press, Lyon

Burke JS (2011) Lymphoproliferative disorders of the gastrointestinal tract. Arch Pathol Lab Med 135:1283–1297CrossRef

Castillo JJ, Bibas M, Miranda RN (2015) The biology and treatment of plasmablastic lymphoma. Blood 125:2323–2330CrossRef

Cellier C, Delabesse E, Helmer C, Patey N, Matuchansky C, Jabri B, Macintyre E, Cerf-Bensussan N, Brousse N (2000) Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. Lancet 356:203–208CrossRef

10.

Choi SY, Kim SJ, Kim WS, Kim K, Ko YH (2011) Aggressive B cell lymphomas of the gastrointestinal tract: clinicopathologic and genetic analysis. Virchows Arch 459:495–502CrossRef

11.

Chott A, Vesely M, Simonitsch I, Mosberger I, Hanak H (1999) Classification of intestinal T-cell neoplasms and their differential diagnosis. Am J Clin Pathol 111(Suppl 1):S68–S74PubMed

12.

Chott A, Haedicke W, Mosberger I, Födinger M, Winkler K, Mannhalter C, Müller-Hermelink HK (1998) Most CD56+ intestinal lymphomas are CD8+CD5− T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol 153:1483–1490CrossRef

13.

Chott A, Gerdes D, Spooner A, Mosberger I, Kummer A, Ebert EC, Blumberg RS, Balk SP (1997) Intraepithelial lymphocytes in normal human intestine do not express proteins associated with cytolytic function. Am J Pathol 151:435–442PubMedPubMedCentral

14.

Connor J, Ashton-Key M (2007) Gastric and intestinal large B-cell lymphomas are clinically and immunophenotypically different. An immunohistochemical and clinical study. Histopathology 51:697–703CrossRef

15.

Copie-Bergman C, Gaulard P, Lavergne-Slove A, Brousse N, Flejou JF, Dordonne K, de Mascarel A, Wotherspoon AC (2003) Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut 52:1656CrossRef

16.

Copie-Bergmann C, Cuilliere-Dartigues P, Baia M, Briere J, Delarue R, Canioni D, Salles G, Parrens M, Belhadj K, Fabiani B, Recher C, Petrella T, Ketterer N, Peyrade F, Haioun C, Nagel I, Siebert R, Jardin F, Leroy K, Jais J-P, Tilly H, Molina TJ, Gaulard P (2015) MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study. Blood 126:2466–2474CrossRef

17.

d’Amore F, Christensen BE, Brincker H, Pedersen NT, Thorling K, Hastrup J, Pedersen M, Jensen MK, Johansen P, Andersen E et al (1991) Clinicopathological features and prognostic factors in extranodal non-Hodgkin’s lymphomas. Danish LYFO Study Group. Eur J Cancer 27:1201–1208CrossRef

18.

Delabie J, Holte H, Vose JM, Ullrich F, Jaffe ES, Savage KJ, Connors JM, Rimsza L, Harris NL, Müller-Hermelink K, Rüdiger T, Coiffier B, Gascoyne RD, Berger F, Tobinai K, Au WY, Liang R, Montserrat E, Hochberg P, Pileri S, Frederico M, Nathwani B, Armitage JO, Weisenburger DD (2011) Enteropatha-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project. Blood 118:148–155CrossRef

19.

Deleeuw RJ, Zettl A, Klinker E, Haralambieva E, Trottier M, Chari R, Gascoyne RD, Chott A, Müller-Hermelink HK, Lam WL (2007) Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 132:1902–1911CrossRef

20.

Dojcinovic SD, Venkatamaran G, Raffeld M, Pittaluga S, Jaffe ES (2010) EBV positive mucocutaneous ulcer-a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol 34:405–417CrossRef

21.

Dubois S, Viailly P-J, Mareschal S et al (2016) Next generation sequencing in diffuse large B cell lymphoma highlights molecular divergence and therapeutic opportunities: a LYSA study. Clin Cancer Res 22:2919–2928CrossRef

22.

Ducreux M, Boutron MC, Piard F, Carli PM, Faivre J (1998) A 15-year series of gastrointestinal non-Hodgkin’s lymphomas: a population-based study. Br J Cancer 77:511–514CrossRef

23.

Farris AB, Lauwers GY, Ferry JA, Zukerberg LR (2008) The rectal tonsil: a reactive lymphoid proliferation that may mimic lymphoma. Am J Surg Pathol 32:1075–1079CrossRef

24.

Fischbach W, Goebeler ME, Ruskone-Formestraux A, Wündisch T, Neubauer A, Raderer M, Savio A, EGILS (European Gastrointestinal Lymphoma Study Group) (2007) Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut 56:1685–1687CrossRef

25.

Fischbach W, Schramm S, Goebeler E (2011) Outcome and quality of life favour a conservative treatment of patients with primary gastric lymphoma. Z Gastroenterol 49:430–435CrossRef

26.

Foss HD, Schmitt GA, Daum S, Anagnostopoulos I, Assaf C, Hummel M, Stein H (1999) Origin of primary gastric T-cell lymphoma from intraepithelial T-lymphocytes: report of two cases. Histopathology 34:9–15CrossRef

27.

Foukas PG, de Leval L (2015) Recent advances in intestinal lymphomas. Histopathology 66:112–136CrossRef

28.

Ganapathi KA, Pittaluga S, Odejide OO, Freedman AS, Jaffe ES (2014) Early lymphoid lesions: conceptual, diagnostic and clinical challenges. Haematologica 99:1421–1432CrossRef

29.

Garcia-Herrera A, Song JY, Chuang S-S, Villamor N, Colomo L, Pittaluga S, Alvato T, Rozman M, Gonzalez J, Arrunategui AM, Fernandez E, Estrach T, Colomer D, Raffeld M, Gaulard P, Campo E, Jaffe ES, Martinez A (2011) Nonhepatosplenic γδT-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol 35:1214–1225CrossRef

30.

Green TM, Nielsen O, de Stricker K, Xu-Monette ZY, Young KH, Moller MB (2012) High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma. Am J Surg Pathol 36:612–619CrossRef

31.

Green TM, Young KH, Visco C, Zijun Y, Xu-Monette XY, Orazi A, Go RS, Nielsen O, Gadberg OV, Mourits-Andersen T, Frederiksen M, Pedersen LM, Moller MB (2012) Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. J Clin Oncol 30:3460–3467CrossRef

32.

Hansen PB, Vogt KC, Skov RL, Pedersen-Bjergaard U, Jacobsen M, Ralfkiaer E (1998) Primary gastrointestinal non-Hodgkin’s lymphoma in adults: a population-based clinical and histopathological study. J Intern Med 244:71–78CrossRef

33.

Harris NL, Ferry JA, Swerdlow SH (1997) Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop. Sem Diagnost Pathol 14:8–14

34.

Hoeller S, Tzankov A, Stenner F, Dirnhofer S (2015) When and how to test for C-MYC in aggressive B cell lymphomas. J Haematop 8:13–20CrossRef

35.

Isaacson PG, Norton AJ (1994) Extranodal lymphomas. Churchill Livingstone, New York, S 44–45

36.

Iwamuro M, Okada H, Takata K, Takenaka R, Inaba T, Mizuno M, Kobashi H, Tanaka S, Yoshioka M, Kondo E, Yoshino T, Yamamoto K (2016) Colorectal manifestation of follicular lymphoma. Intern Med 55:1–8CrossRef

37.

Kanungo A, Medeiros LJ, Abruzzo LV, Lin P (2006) Lymphoid neoplsms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis. Mod Pathol 19:25–33CrossRef

38.

Kawamoto K, Nakamura S, Iwashita A, Watanabe J, Oshiro Y, Nakayama Y, Nimura S, Kimura N, Aoyagi K, Yao T, Kuramochi S, Matsuyama A, Kurihara K, Ohshima K, Takeshita M (2009) Clinicopathological characteristics of primary gastric T-cell lymphoma. Histopathology 55:641–653CrossRef

39.

Kendrick SL, Redd L, Muranyi A, Henricksen LA, Stanislaw S, Smith LM, Perry AM, Fu K, Weisenburger DD, Rosenwald A, Ott G, Gascoyne RD, Jaffe ES, Campo E, Delabie J, Braziel RM, Cook JR, Tubbs RR, Staudt LM, Chan WC, Steidl C, Grogan TM, Rimsza LM (2014) BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B cell lymphoma. Hum Pathol 45:2144–2153CrossRef

40.

Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W, Grothaus-Pinke B, Reinartz G, Brockmann J, Temmelsfeld A, Schmitz R, Rübe C, Probst A, Jaenke G, Bodenstein H, Junker A, Pott C, Schultze J, Heinecke A, Parwaresch R, Tiemann M (2001) Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol 19:3861–3873CrossRef

41.

Kumar S, Fend F, Quintanilla-Martinez L, Kingma DW, Sorbara L, Raffeld M, Banks PM, Jaffe ES (2000) Epstein-Barr Virus-positive primary gastrointestinal Hodgkin’s disease. Association with inflammatory bowel disease and immunosuppression. Am J Surg Pathol 24:66–73CrossRef

42.

Kuo S-H, Yeh K-H, Wu M-S, Lin C-W, Hsu P-N, Wang H-P, Cheng A-L et al (2012) Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas. Blood 119:4838–4844CrossRef

43.

Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F, Bengoufa D, Feuillard J, Lavergne A, Gordon JI, Berche P, Guellevin L, Lortholary O (2004) Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 350:239–248CrossRef

44.

Liang R, Todd D, Chan TK, Chiu E, Lie A, Kwong YL, Choy D, Ho FC (1995) Prognostic factors for primary gastrointestinal lymphoma. Hematol Oncol 13:153–163CrossRef

45.

Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C, Lavergne A, Boot H, Caletti G, Wundisch T, Molina T, Taal BG, Elena S, Thomas T, Zinzani PL, Neubauer A, Stolte M, Hamoudi RA, Dogan A, Isaacson PG, Du MQ (2002) T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 122:1286–1294CrossRef

46.

Malamut G, Meresse B, Kaltenbach B, Derrieux C, Verkarre V, Macintyre E, Ruskone-Formestraux A, Fabiani B, Radford-Weiss I, Brousse N, Hermine O, Cerf-Bensussan N, Cellier C (2014) Small intestinal CD4+ T-cell lymphoma is a heterogeneous entity with common pathology features. Clin Gastroenterol Hepatol 12:599–608CrossRef

47.

Mamessier E, Song JY, Eberle FC, Pack S, Drevet C, Chetaille B, Abdullaev Z, Adelaide J, Birnbaum D, Chaffanet M, Pittaluga C, Roulland S, Chott A, Jaffe ES, Nadel B (2014) Early lesions of follicular lymphoma: a genetic perspective. Haematologica 99:481–488CrossRef

48.

Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, Jaffe ES (2011) NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood 117:1447–1452CrossRef

49.

Margolskee E, Jobanputra V, Lewis S, Alobeid B, Green PHR, Bhagat G (2013) Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity wit unique biologic and clinic features. PLoS ONE 8:e68343CrossRef

50.

Morgan EA, Pihan GA, Said JW, Yu HY, Pinkus JL, Dorfman DM, Rodig SJ, Pinkus GS (2014) Profile of CD103 expression in T-cell neoplasms. Immunoreactivity is not restricted to enteropathy-associated T-cell lymphoma. Am J Surg Pathol 38:1557–1570CrossRef

51.

Morton JE, Leyland MJ, Hudson GV, Hudson BV, Anderson L, Bennett MH, MacLennan KA (1993) Primary gastrointestinal non-Hodgkin’s lymphoma: a review of 175 British National Lymphoma Investigation cases. Br J Cancer 67:776–782CrossRef

52.

Musshoff K (1977) Klinische Stadieneinteilung der nicht-Hodgkin Lymphome. Strahlentherapie 153:218–221PubMed

53.

Nakamura S, Ye H, Bacon CM, Goatly A, Liu H, Kerr L, Banham AH, Streubel B, Yao T, Tsuneyoshi M, Savio A, Takeshita M, Dartigues P, Ruskone-Formestraux A, Matsumoto T, Iida M, Du M-Q (2008) Translocations involving the Immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma. Clin Cancer Res 14:3002–3010CrossRef

54.

Ok CY, Papathomas TG, Medeiros LJ, Young KH (2013) EBV+ diffuse large B-cell lymphoma of the elderly. Blood 122:328–340CrossRef

55.

O’Leary AD, Sweeney EC (1986) Lymphoglandular complexes of the colon: structure and function. Histopathology 10:267–283CrossRef

56.

Pals ST, de Gorter DJJ, Spaargaren M (2007) Lymphocyte dissemination: the other face of lymphocyte homing. Blood 110:3102–3111CrossRef

57.

Pongpruttipan T, Sukpanichnant S, Assanasen T, Wannakrairot P, Boonsakan P, Kanoksil W, Kayasut K, Mitarnun W, Khuhapinant A, Bunworasate U, Puavilai T, Bedavanija A, Garcia-Herrera A, Campo E, Cook JR, Choi J, Swerdlow SH (2012) Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and αβ, γδ and αβ/γδ T-cell origin: a comprehensive clinicopathologic and phenotypic study. Am J Surg Pathol 36:481–499CrossRef

58.

Price SK (1990) Immunoproliferative small intestinal disease. A study of 13 cases with alpha heavy-chain disease. Histopathology 17:7–17CrossRef

59.

Radaszkiewicz T, Dragosics B, Bauer P (1992) Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology 102:1628–1638CrossRef

60.

Raderer M, Wöhrer S, Streubel B, Troch M, Turetschek K, Jäger U, Skrabs K, Gaiger A, Drach J, Puespoek A, Formanek M, Hoffmann M, Hauff W, Chott A (2006) Importance of extensive staging in patients with mucosa.associated lymphoid tissue (MALT)-type lymphoma. J Clin Oncol 24:3136–3141CrossRef

61.

Raderer M, Wöhrer S, Kiesewetter B, Dolak W, Lagler H, Wotherspoon A, Muellauer L, Chott A (2015) Antibiotic treatment as sole management of Helicobacter pylori –negative gastric MALT lymphoma: a single center experience with prolonged follow-up. Ann Hematol 94:980–984CrossRef

62.

Rodig SJ, Vergilio J-A, Shahsafaei MS, Dorfman DM (2008) Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation. Am J Surg Pathol 32:113–122CrossRef

63.

Rohatiner A, d’Amore F, Coiffier B et al (1994) Report on a workshop convened to discuss the pathological and staging classification of gastrointestinal tract lymphoma. Ann Oncol 5:397–400CrossRef

64.

Ruskone-Formestraux A, Fischbach W, Aleman BMP, Boot H, Du MQ, Megraud F, Montalban C, Raderer M, Savio A, Wotherspoon A, EGILS group (2011) EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 60:747–758CrossRef

65.

Ruskoné-Fourmestraux A, Delmer A, Lavergne A, Molina T, Brousse N, Audouin J, Rambaud J (1997) Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 32 cases. Gastroenterology 112:7–16CrossRef

66.

Salmi M, Jalkanen S (2005) Lymphocyte homing to the gut: attraction, adhesion and commitment. Immunol Rev 206:100–113CrossRef

67.

Schiefer AI, Kornauth C, Simonitsch-Klupp I, Skrabs C, Masel EK, Streubel B, Vanura K, Walter K, Migschitz B, Stoiber T, Sexl V, Raderer M, Chott A, da Silva MG, Cabecadas J, Müllauer L, Jäger U, Porpaczy E (2015) Impact of single or combined genomic alterations of TP53, MYC, and BCL2 on survival of patients with diffuse large B-cell lymphomas: a retrospective cohort study. Medicine (Baltimore) 94:e2388CrossRef

68.

Schmatz A-I, Streubel B, Kretschmer-Chott E, Püspök A, Jäger U, Mannhalter C, Tiemann M, Fischbach W, Herzog P, Seitz G, Stolte M, Raderer M, Chott A (2011) Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. J Clin Oncol 29:1445–1451CrossRef

69.

Schmitz R, Ceribelli M, Pittaluga S, Wright G, Staudt LM (2014) Oncogenic mechanisms in Burkitt Lymphoma. Cold Spring Harb Perspect Med 4:a14282CrossRef

70.

Shimada HM, Fukayama H, Hayashi J, Ushijima T, Suzuki M, Hishima T, Funata N, Koike M, Watanabe T (1997) Primary gastric T-cell lymphoma with and without human T-lymphotropic virus type 1. Cancer 80:292–303CrossRef

71.

Slack GW, Gascoyne RD (2011) MYC and aggressive B-cell lymphomas. Adv Anat Pathol 18:219–228CrossRef

72.

Soldini D, Valera A, Sole C, Palomero J, Amador V, Martin-Subero JI, Ribero-Cortada I, Royo C, Salaverria I, Bea S, Gonzalvo E, Johannesson H, Herrera M, Colomo L, Martinez A, Campo E (2014) Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma. Am J Surg Pathol 38:86–93CrossRef

73.

Streubel B, Seitz G, Stolte M, Birner B, Chott A, Raderer M (2006) MALT lymphoma associated genetic aberrations occur at different frequencies in primary and secondary intestinal MALT lymphomas. Gut 55:1581–1585CrossRef

74.

Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon

75.

Takeuchi K, Yokoyama M, Ishizawa S, Terui Y, Nomura K, Marutsuka K, Nunomura M, Fukushima N, Yagyuu T, Nakamine H, Akiyama F, Hoshi K, Matsue K, Hatake K, Oshimi K (2010) Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood 116:5631–5637CrossRef

76.

Tan S-Y, Chuang S-S, Tang T, Tan L, Ko Y-H, Chuah K-L, Ng S-B, Chng W-J, Gatter K, Loong F, Liu Y-H, Hosking P, Cheah P-L, The B-T, Tay K, Koh M, Lim S-T (2013) Type II EATL (epitheliotropic imtestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype. Leukemia 27:1688–1696CrossRef

77.

Troch M, Woehrer S, Streubel B, Weissel M, Hoffmann M, Müllauer L, Chott A, Raderer M (2008) Chronic autoimmune thyro’s thyroiditis) in patients with MALT lymphoma. Ann Oncol 19:1336–1339CrossRef

78.

Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Li Y, Tzankov A, Wen W, Liu W-M, Kahl BS, d’Amore ESG, Montes-Moreno S, Dybkaer K, Chiu A, Tam W, Orazi A, Zu Y, Bhagat G, Winter JN, Wang HJ, O’Neill S, Dunphy CH, His ED, Zhao XF, Go RS, Choi WWL, Zhou F, Czader M, Tong J, Zhao X, van Krieken JH, Huang Q, Ai W, Etzell J, Ponzoni M, Ferreri AJM, Piris MA, Moller MB, Bueso-Ramos CE, Medeiros LJ, Wu L, Young KH (2012) Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia 26:2103–2113CrossRef

79.

Wöhrer S, Troch M, Streubel B, Hoffmann M, Müllauer L, Chott A, Raderer M (2007) Pathology and clinical course of MALT lymphoma with plasmacytic differentiation. Ann Oncol 18:2020–2024CrossRef

80.

Ye H, Liu H, Attygalle et al (2003) Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood 102:1012–1018CrossRef

81.

Zettl A, Rüdiger T, Müller-Hermelink HK (2007) Pathologie und Pathogenese des Enteropathie-assoziirten T-Zell-Lymphoms. Pathologe 28:59–64CrossRef

82.

Zettl A, Ott G, Makulik A, Katzenberger T, Starostik P, Eichler T, Puppe B, Bentz M, Müller-Hermelink HK, Chott A (2002) Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma. Am J Pathol 161:1635–1645CrossRef

83.

Zhang W-Y, Li G-D, Liu W-P, Ouyang Q, Ren X-C, Li F-Y, Xu H (2005) Features of intestinal T-cell lymphomas in Chinese population without evidence of celiac disease and their close association with Epstein-Barr virus infection. Chin Med J 118:1542–1548PubMed

84.

Zullo A, Hassan C, Cristofari F, Andriani A, De Francesco V, Ierardi E, Tomao S, Stolte M, Morini S, Vaira D (2010) Effects of Helicobacter pylori eradication on early gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 8:105–110CrossRef

Titel: Lymphproliferative Erkrankungen des Gastrointestinaltrakts
verfasst von: Univ. Prof. Dr. Andreas Chott
Verlag: Springer Berlin Heidelberg
Buch: Pathologie
Print ISBN: 978-3-540-85183-7

Electronic ISBN: 978-3-540-85184-4

Copyright-Jahr: 2019
DOI: https://doi.org/10.1007/978-3-540-85184-4_35

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

35. Lymphproliferative Erkrankungen des Gastrointestinaltrakts

Zusammenfassung

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren